In Utero Therapy for Congenital Diaphragmatic Hernia

Marisa E Schwab1, Hanmin Lee2, KuoJen Tsao3

  • 1Division of Pediatric Surgery, University of California San Francisco, 550 16th Street, San Francisco, San Francisco, CA 94158, USA; Department of Surgery, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA.

Clinics in Perinatology
|November 3, 2022
PubMed

Insights

Congenital diaphragmatic hernia (CDH) is a severe defect often diagnosed before birth. Fetal intervention, particularly fetal endoscopic tracheal occlusion, shows promise for improving outcomes in affected fetuses.

Area of Science:

  • Medical research
  • Fetal medicine
  • Surgical innovation

Background:

  • Congenital diaphragmatic hernia (CDH) presents a wide spectrum of severity.
  • Severe CDH cases are linked to high fetal morbidity and mortality.
  • CDH is a significant target for prenatal therapeutic strategies.

Purpose of the Study:

  • To review the current literature on prenatal diagnosis of CDH.
  • To outline the historical development of fetal interventions for CDH.
  • To discuss fetal endoscopic tracheal occlusion (FETO) and its trial results.

Main Methods:

  • Literature review of prenatal diagnosis and fetal intervention for CDH.
  • Analysis of historical approaches to fetal therapy for CDH.
  • Discussion of fetal endoscopic tracheal occlusion techniques and outcomes.

Main Results:

  • Prenatal diagnosis of CDH is established, with varying disease spectra.
  • Fetal intervention is a viable strategy for severe CDH.
  • Tracheal Occlusion To Accelerate Lung growth (TOTAL) trial data provides insights into FETO efficacy.

Conclusions:

  • Congenital diaphragmatic hernia management benefits from fetal intervention.
  • Fetal endoscopic tracheal occlusion is a developing therapeutic option.
  • Future preclinical studies may offer novel directions for CDH treatment.

Related Concept Videos